Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

The impact of PDD during TURB for NMIBC: a prospective randomized controlled trial Pending

2024-514316-27-00 Not muscular invasive bladder cancer 6
A clinical study on SHR3680 combined with androgen deprived therapy (ADT) versus Bicalutamide combined with ADT in treatment of prostate can… Pending

2024-515194-10-00 Metastatic hormone-sensitive prostate cancer with high 5
Double-T - Improving outcomes in high-risk 2nd line relapsed/refractory Large B-Cell Lymphoma patients eligible for CAR-T-cell therapy with … Pending

2025-523806-34-00 relapsed/refractory Large B-Cell Lymphoma 4
SPatial Heterogeneity of INtratumoral drug distribution Pending

2025-520530-32-00 ER+ HER2- Breast cancer 6
A trial to learn how safe different combinations of anti-cancer drugs are and how well they work in adults with advanced or metastatic non-s… Pending

2025-524843-11-00 Non-Small Cell Lung Cancer 4
Immune checkpoint inhibitors and Carbon iON radiotherapy In solid Cancers with stable disease (ICONIC) Pending

2024-517378-22-00 Unresectable or metastatic melanoma 4
A phase 1/2a, first-in-human, open-label, dose-escalating study with a safety expansion cohort to evaluate safety, tolerability, pharmacokin… Pending

2025-521164-36-00 Patients with relapsed/refractory advanced/metastatic o 7
A clinical study of MK-1045 in people with non-Hodgkin lymphoma (MK-1045-008) Pending

2025-523005-15-00 Non-Hodgkin Lymphoma 9
A study investigating the safety and efficacy of academically-produced CAR T cells compared with standard treatment for patients with multip… Pending

2025-524876-43-00 relapsed/refractory multiple myeloma 5
BALLAD Belgium - A trial to evaluate the potential benefit of adjuvant chemotherapy for small bowel adenocarcinoma. The Belgian component of… Pending

2024-518349-85-01 small bowel adenocarcinoma 5
A Study of LY4257496 in Participants With Cancer (OMNIRAY) Pending

2025-522367-15-00 Breast Neoplasms Colorectal Neoplasms Prostate Neoplasm 1
MInimal residual Disease Adapted Strategy / IFM 2020-02 Pending

2024-513889-19-00 Multiple Myeloma 5
First-in-Human Trial of DS3610a in Participants with Advanced Solid Tumors Pending

2025-521173-13-00 Advanced Solid Tumors 1
Study of the combination of the drug ASP-1929 and light illumination with the device PIT690 laser system in addition with pembrolizumab vers… Pending

2025-523017-28-00 Locoregional Recurrence of Squamous Cell Carcinoma of t 5
Safety and Efficacy of Neoadjuvant immunotherapy with Durvalumab (MEDI 4736) in combination with neoadjuvant chemotherapy (Gemcitabin/Cispla… Pending

2024-516077-72-02 The patient has a histologically-confirmed (ureteroscop 4
Use of the chemotherapy FOLFIRI and cetuximab if given with treatment breaks or continuously in patients with newly diagnosed metastatic col… Pending

2025-522377-12-00 metastatic colorectal cancer 5
Improved baseline staging with 68Ga-FAPI-46 PET in non-small cell lung cancer – a pilot study Pending

2025-523032-39-00 Non-small cell lung cancer 4
A Phase 1, multicenter, open-label study of REM-422, a MYB mRNA degrader, in patients with recurrent or metastatic, adenoid cystic carcinoma… Pending

2023-508476-11-00 Adenoid cystic carcinoma (ACC) 1
Targeted fluorescence endoscopy for detection of the primary cancer lesion in patients with a metastasis of unknown primary tumor in the hea… Pending

2024-513897-23-00 Unknown primary tumour of the head and neck 4
Boosting osimertinib Blood Brain Barrier penetration in patients with epidermal growth factor receptor mutated non-small cell lung cancer (O… Pending

2025-523033-26-00 Patients with EGFR-mutated metastatic NSCLC, without CN 4
TOTAL NEOADJUVANT TREATMENT WITHOUT SURGERY FOR LOCALLY ADVANCED RECTAL CANCER: PROSPECTIVE CLINICAL TRIAL TO ASSESS TUMOR COMPLETE RESPONSE… Pending

2024-515225-28-00 Adenocarcinoma of the medium/lower rectum in Stage II ( 10
DAREON®-Lung-1: A study in people with advanced small cell lung cancer to compare obrixtamig plus atezolizumab, carboplatin, and etoposide t… Pending

2025-520565-51-00 small cell lung cancer 5
An open label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioequivalence study comparing Imatini… Pending

2025-524935-38-00 Acute Lymphoblastic Leukemia (Ph+ ALL) 2
A prospective, open-label, randomized, multicenter phase-III trial to evaluate the efficacy of pirtobrutinib and epcoritamab compared with R… Pending

2024-513445-37-00 previously untreated RT, irrespective of risk factors a 5